Top Markets
#1 Siren Siren +35.00%
#2 TDCCP TDCCP +20.44%
#3 aelf aelf +17.29%
#4 DAPPOS DAPPOS +14.71%
#5 Status Status +7.72%
#6 Tutorial Tutorial +7.24%
#7 DeXe DeXe +6.91%
#8 GRVT Token GRVT Token +6.69%
#9 HOME HOME +6.45%
#10 OpenGradient OpenGradient +6.28%
Coin of the day
Siren Siren
Settings
Language
ENGLISH
Currency
USD
Theme
Sinopep-Allsino Bio Pharmaceutical Co.,Ltd. Sinopep-Allsino Bio Pharmaceutical Co.,Ltd.

Sinopep-Allsino Bio Pharmaceutical Co.,Ltd.

688076
Rank in Stocks #8443
Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd., a biomedical company,... Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd., a biomedical company, engages in the research and development, production, and sale of peptides, oligonucleotides, and small molecule drugs in China. The company offers Peptide CDMO Services,GMP oligo, full-time equivalent, discovery, generic APIs, and formulation services. It is also involved in professional technical services. The company was founded in 2009 and is headquartered in Hangzhou, China.
Share Price
$3.99
Last synced: 2026-08-28
Market Cap
$1.26B
Change (1 day)
-0.04%
Change (1 year)
-33.48%
Country
CN
Trade Sinopep-Allsino Bio Pharmaceutical Co.,Ltd. (688076)

Category

Healthcare
P/E ratio for Sinopep-Allsino Bio Pharmaceutical Co.,Ltd. (688076)
P/E ratio as of 2026 TTM: 0
According to Sinopep-Allsino Bio Pharmaceutical Co.,Ltd. latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0. At the end of 2026 the company had a P/E ratio of 0.
P/E ratio history for Sinopep-Allsino Bio Pharmaceutical Co.,Ltd. from 2026 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
Not enough data for the provided dates.
P/E ratio for similar companies or competitors
Company P/E Ratio P/E Ratio Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 29.20 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 30.62 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 32.46 -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 -7.93 -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.